Compared to the conventional single-nozzle emitters, the M3 emitter from Newomics provides 3-5 times higher peptide signals in ESI-MS and more robust and stable spray across the LC gradient. This allows me to use microliter flow rate LC-MS for a large set of biological samples for biomarker discovery, and ensures the reproducible results and similar sensitivity as nanoLC-MS has.
Newomics Inc. is a commercial-stage biotechnology company that sells and develops innovative (New) and integrative (Omics) platforms and solutions for precision medicine.